六甲基三聚氰胺的体内研究。 - Suppr

Suppr

超能文献

In vivo studies with hexamethylmelamine.

作者信息

Rutty C J, Connors T A, Hoellinger H

出版信息

Eur J Cancer (1965). 1978 Jun;14(6):713-20. doi: 10.1016/0014-2964(78)90308-0.

DOI:10.1016/0014-2964(78)90308-0

PMID:95953

Abstract

摘要

相似文献

In vivo studies with hexamethylmelamine.

Eur J Cancer (1965). 1978 Jun;14(6):713-20. doi: 10.1016/0014-2964(78)90308-0.

Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma.

Cancer Chemother Pharmacol. 1983;11(1):51-5. doi: 10.1007/BF00257418.

In vivo and in vitro irreversible binding of hexamethylmelamine to liver and ovarian tumor macromolecules of mice.

Biochem Pharmacol. 1981 May 15;30(10):1151-4. doi: 10.1016/0006-2952(81)90458-5.

Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.

Cancer Treat Rep. 1982 Jan;66(1):127-33.

Rapid formation of N-hydroxymethylpentamethylmelamine by mitochondria from rat small intestinal epithelium.

Life Sci. 1983 Nov 21;33(21):2113-9. doi: 10.1016/0024-3205(83)90335-1.

In vitro cytotoxicity of the methylmelamines.

Chem Biol Interact. 1980 Feb;29(2):235-46. doi: 10.1016/0009-2797(80)90036-8.

Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.

Cancer Treat Rep. 1981 Jul-Aug;65(7-8):669-72.

Metabolic activation of hexamethylmelamine and pentamethylmelamine by liver microsomal preparations.

Life Sci. 1981 Oct 12;29(15):1591-8. doi: 10.1016/0024-3205(81)90261-7.

Uptake and metabolism of hexamethylmelamine and pentamethylmelamine by L5178Y lymphoblasts in vitro.

Cancer Res. 1980 Dec;40(12):4489-94.

Cellular and subcellular studies of the biotransformation of hexamethylmelamine in rat isolated hepatocytes and intestinal epithelial cells.

Cancer Res. 1984 Jul;44(7):2820-6.

引用本文的文献

Altretamine for the treatment of metastatic renal cell carcinoma. A Hoosier Oncology Group trial.

Invest New Drugs. 2001;19(3):229-31. doi: 10.1023/a:1010620601431.

Clinical pharmacokinetics of altretamine.

Clin Pharmacokinet. 1995 Jun;28(6):439-48. doi: 10.2165/00003088-199528060-00002.

Altretamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cancer chemotherapy.

Drugs. 1995 Jun;49(6):932-53. doi: 10.2165/00003495-199549060-00007.

British Association for Cancer Research 22nd Annual general meeting. 13-15 April 1981. Abstracts.

Br J Cancer. 1981 Aug;44(2):271-315.

The comparative pharmacokinetics of pentamethylmelamine in man, rat, and mouse.

Cancer Chemother Pharmacol. 1982;8(1):105-11. doi: 10.1007/BF00292880.

In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.

Br J Cancer. 1981 Aug;44(2):189-200. doi: 10.1038/bjc.1981.170.

Time dependence of the in vitro cytotoxicity of hexamethylmelamine and its metabolites.

Br J Cancer. 1980 Apr;41(4):630-5. doi: 10.1038/bjc.1980.106.

Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts.

Br J Cancer. 1981 Apr;43(4):458-63. doi: 10.1038/bjc.1981.67.

Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines.

Cancer Chemother Pharmacol. 1985;15(1):49-53. doi: 10.1007/BF00257294.

N-methyl antitumour agents. A distinct class of anticancer drugs?

Cancer Chemother Pharmacol. 1987;19(2):91-102. doi: 10.1007/BF00254559.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验